Device evaluation of the monitor and electrode belt has been completed.The evaluation included review of downloaded software flag files on the day of the event and incoming functional testing.During the incoming functional testing, a 1hz simulated normal sinus rhythm signal was applied to the ecg electrodes, followed by a 5hz simulated treatable arrhythmia signal which verified proper performance of the detection algorithm.During the transition to the 5hz signal, the device was confirmed to properly enter into a treatment sequence which includes a verification of the tactile vibration alarm, audio messaging, and siren alarms, as well as a test of the pulse delivery circuitry.The pulse delivery circuitry test verified proper charging of the high voltage capacitors and proper delivery of five full energy 150j biphasic pulses.The functional testing confirmed proper response button functionality, ecg acquisition, detection algorithm performance, and pulse delivery functionality.There is no indication of a product malfunction.Device manufacture date: monitor 08/19/2019; belt 12/28/2018.
|
A us distributor contacted zoll to report that a patient passed away while wearing the lifevest on (b)(6) 2021.Per clinical review of the continuous ecg recording, the device was started up at 08:01:01 on (b)(6) 2021.The patient was in sinus bradycardia at 50 bpm at 22:42:41, slowing to 10 bpm before degrading to asystole with intermittent cardiac activity and cpr/motion artifact by 22:45:56.The patient was in an idioventricular rhythm at 90 bpm with cpr/motion artifact at 22:49:08.The patient's rhythm transitioned to vt at 120 bpm with cpr/motion artifact and electrode lead fall off at 22:50:22.The electrode belt was disconnected at approximately 22:50:35.Cpr/motion artifact, the rate of the vt being below the physician-prescribed rate threshold of 150 bpm, and the electrode belt disconnection prevented the lifevest from detecting the vt arrhythmia.It was not reported who disconnected the electrode belt.
|